Research ArticleClinical Studies

Safety and Effectiveness of Ixazomib Dose-escalating Strategy in Ixazomib-Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma

YASUKATA OHASHI, MEGUMI YATABE, DAISUKE NIIJIMA, KENTARO TANI, CHIAKI OGAWA, YUTAKA YACHI, TOSHIYA KAGOO, SAIGEN BOKU, HIRONORI UENO, TAKAHIRO YANO, KOJI HIGAI and AKIHIRO YOKOYAMA
In Vivo September 2020, 34 (5) 2821-2828; DOI: https://doi.org/10.21873/invivo.12108

Article Information

vol. 34 no. 5 2821-2828
DOI 
https://doi.org/10.21873/invivo.12108
PMID 
32871820
Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received May 1, 2020
  • Revision received June 2, 2020
  • Accepted June 10, 2020
  • Published online August 31, 2020.
Copyright & License 
Copyright © 2020 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. YASUKATA OHASHI1,2⇑,
  2. MEGUMI YATABE1,
  3. DAISUKE NIIJIMA1,
  4. KENTARO TANI1,
  5. CHIAKI OGAWA1,
  6. YUTAKA YACHI1,
  7. TOSHIYA KAGOO3,
  8. SAIGEN BOKU3,
  9. HIRONORI UENO3,
  10. TAKAHIRO YANO3,
  11. KOJI HIGAI2 and
  12. AKIHIRO YOKOYAMA3,4
  1. 1Department of Pharmacy, National Hospital Organization Tokyo Medical Center, Tokyo, Japan
  2. 2Laboratory of Medical Biochemistry, Faculty of Pharmaceutical Sciences Toho University, Chiba, Japan
  3. 3Division of Hematology, National Hospital Organization Tokyo Medical Center, Tokyo, Japan
  4. 4Division of Transfusion Medicine, National Hospital Organization Tokyo Medical Center, Tokyo, Japan
  1. Correspondence to: Yasukata Ohashi, Department of Pharmacy, National Hospital Organization Tokyo Medical Center, 2-5-1 Higashigaoka Meguro-ku, Tokyo 152-8902, Japan. Tel: +81 334110111, Fax: +81 334115488, E-mail: yasu970554126{at}gmail.com
View Full Text

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Print
Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Safety and Effectiveness of Ixazomib Dose-escalating Strategy in Ixazomib-Lenalidomide-Dexamethasone Treatment for Relapsed/Refractory Multiple Myeloma
YASUKATA OHASHI, MEGUMI YATABE, DAISUKE NIIJIMA, KENTARO TANI, CHIAKI OGAWA, YUTAKA YACHI, TOSHIYA KAGOO, SAIGEN BOKU, HIRONORI UENO, TAKAHIRO YANO, KOJI HIGAI, AKIHIRO YOKOYAMA
In Vivo Sep 2020, 34 (5) 2821-2828; DOI: 10.21873/invivo.12108
Twitter logo Facebook logo Mendeley logo

Jump to section

Keywords